Clinical Trials Directory

Trials / Sponsors / Chromaderm, Inc.

Chromaderm, Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedRenal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus
Diabetes Mellitus, Type 1
Phase 32006-03-01
CompletedTreatment for Completers of the Study B7A-MC-MBCM
Diabetic Retinopathy
Phase 32006-01-01
CompletedEffect of Ruboxistaurin on Clinically Significant Macular Edema
Diabetic Macular Edema
Phase 32005-08-01
CompletedThe Effect of Ruboxistaurin on Small Fiber Function
Diabetic Neuropathy
Phase 22004-10-01
CompletedReduction in the Occurrence of Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 32004-02-01
CompletedEffect of LY333531 on Vascular and Neural Functions
Diabetes Mellitus
Phase 22003-12-01
CompletedIsoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in
Diabetes Mellitus
Phase 12002-09-01
CompletedThe Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes
Diabetic Nephropathy
Phase 22002-07-16
CompletedTreatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
Diabetic Neuropathies, Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Non-Insulin-Dependent
Phase 32002-07-01
CompletedProtein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
Diabetic Retinopathy
Phase 32001-03-01